These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6452931)

  • 1. [Mechanism of action of an anticonvulsant, sodium dipropylacetate].
    Simler S; Ciesielski L; Klein M; Gobaille S; Mandel P
    C R Seances Soc Biol Fil; 1981; 175(1):114-9. PubMed ID: 6452931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GABA shunt deficiencies and accumulation of reactive oxygen intermediates: insight from Arabidopsis mutants.
    Fait A; Yellin A; Fromm H
    FEBS Lett; 2005 Jan; 579(2):415-20. PubMed ID: 15642352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Purification of rat brain succinate-semialdehyde dehydrogenase and study of its inhibition by branched chain fatty acids].
    Cash C; Ciesielski L; Maitre M; Mandel P
    C R Seances Soc Biol Fil; 1975; 169(4):884-7. PubMed ID: 129258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. gamma-Hydroxybutyrate conversion into GABA induces displacement of GABAB binding that is blocked by valproate and ethosuximide.
    Hechler V; Ratomponirina C; Maitre M
    J Pharmacol Exp Ther; 1997 May; 281(2):753-60. PubMed ID: 9152382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Di-n-propylacetate and GABA degradation. Preferential inhibition of succinic semialdehyde dehydrogenase and indirect inhibition of GABA-transaminase.
    van der Laan JW; de Boer T; Bruinvels J
    J Neurochem; 1979 Jun; 32(6):1769-80. PubMed ID: 376783
    [No Abstract]   [Full Text] [Related]  

  • 6. Influence of a GABA transaminase inhibitor on central nervous system oxygen toxicity.
    Harel D; Raday-Bitterman N; Kerem D
    Aviat Space Environ Med; 1978 Jul; 49(7):877-9. PubMed ID: 352331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of Erigeron breviscapus extract and its flavonoid components on GABA shunt enzymes.
    Tao YH; Jiang DY; Xu HB; Yang XL
    Phytomedicine; 2008 Jan; 15(1-2):92-7. PubMed ID: 17689232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of sodium n-dipropylacetate on the GABA level in various areas of the mouse brain].
    Simler S; Gensburger C; Ciesielski L; Mandel P
    C R Seances Soc Biol Fil; 1976; 170(6):1285-8. PubMed ID: 140750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of GABA shunt enzymes' activity by 4-hydroxybenzaldehyde derivatives.
    Tao YH; Yuan Z; Tang XQ; Xu HB; Yang XL
    Bioorg Med Chem Lett; 2006 Feb; 16(3):592-5. PubMed ID: 16290145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of sodium n-dipropylacetate (sodium valproate) on GABA level of neuronal and glial cells in culture].
    Gensburger C; Simler S; Ciesielski L; Mandel P
    C R Seances Soc Biol Fil; 1978; 172(4):701-6. PubMed ID: 218700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated endogenous GABA level correlates with decreased fMRI signals in the rat brain during acute inhibition of GABA transaminase.
    Chen Z; Silva AC; Yang J; Shen J
    J Neurosci Res; 2005 Feb; 79(3):383-91. PubMed ID: 15619231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Succinic semialdehyde dehydrogenase deficiency: GABAB receptor-mediated function.
    Buzzi A; Wu Y; Frantseva MV; Perez Velazquez JL; Cortez MA; Liu CC; Shen LQ; Gibson KM; Snead OC
    Brain Res; 2006 May; 1090(1):15-22. PubMed ID: 16647690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Succinic semialdehyde couples stress response to quorum-sensing signal decay in Agrobacterium tumefaciens.
    Wang C; Zhang HB; Wang LH; Zhang LH
    Mol Microbiol; 2006 Oct; 62(1):45-56. PubMed ID: 16942602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vigabatrin and newer interventions in succinic semialdehyde dehydrogenase deficiency.
    Gropman A
    Ann Neurol; 2003; 54 Suppl 6():S66-72. PubMed ID: 12891656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutants of GABA transaminase (POP2) suppress the severe phenotype of succinic semialdehyde dehydrogenase (ssadh) mutants in Arabidopsis.
    Ludewig F; Hüser A; Fromm H; Beauclair L; Bouché N
    PLoS One; 2008; 3(10):e3383. PubMed ID: 18846220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valproic acid: brain and plasma levels of the drug and its metabolites, anticonvulsant effects and gamma-aminobutyric acid (GABA) metabolism in the mouse.
    Nau H; Löscher W
    J Pharmacol Exp Ther; 1982 Mar; 220(3):654-9. PubMed ID: 6801254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of chronic treatment with the GABA transaminase inhibitors gamma-vinyl GABA and ethanolamine O-sulphate on the in vitro GABA release from rat hippocampus.
    Qume M; Fowler LJ
    Br J Pharmacol; 1997 Oct; 122(3):539-45. PubMed ID: 9351512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ontogeny of GABA pathway in human fetal brains.
    Das SK; Ray PK
    Biochem Biophys Res Commun; 1996 Nov; 228(2):544-8. PubMed ID: 8920949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of certain GABA-ergic substances on dopamine metabolism in the rat brain].
    Malikova LA; Arefolov VA
    Farmakol Toksikol; 1981; 44(1):37-40. PubMed ID: 6790298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroinformatics analyses reveal GABAt and SSADH as major proteins involved in anticonvulsant activity of valproic acid.
    Piplani S; Verma PK; Kumar A
    Biomed Pharmacother; 2016 Jul; 81():402-410. PubMed ID: 27261619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.